2014, BioTech, Health Policy and Medicare

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

BioTech

Health Policy

Medicare

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

A recent study on politics and health care spending in the U.S. published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. In the words of NPR, “Hospitals are the largest individual contributor to health care costs in the U.S…

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. A cost of $125 or more yields abandonment of at least 50%.

Medicare

Medicare BioTech Pharmaceuticals Mental health

Connected Health Pulse

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Stay Connected